Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...
News Medical on MSN
Leukemia That Starts Before Birth Is More Aggressive
A Mount Sinai team showed that the same leukemia mutation behaves differently depending on when it arises during development.
Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...
Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...
Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback